A new study revealed no significant relationship between patients with juvenile idiopathic arthritis and exposure to maternal infection, however, investigators said that suggestive evidence of differential sex-specific results indicate a need for further study.
Investigators have wondered if maternal infection had any influence on childhood autoimmune disorders like type I diabetes. However, due to the lack of substantial literature around juvenile idiopathic arthritis (JIA), Anna Sutton, MPH, Department of Epidemiology, University of Washington School of Public Health, decided to lead an investigation on the association between JIA and maternal infection.
The results didn't show that children who were exposed to maternal infection had an increased risk of juvenile idiopathic arthritis. Although, investigators stated that there was suggestive evidence of differential sex-specific results that should be studied further.
While the outcomes of this case-controlled study didn't indicate a significant association for the primary relationship in question, in the sex-stratified analysis, data suggested the potential that juvenile idiopathic arthritis has an increased correlation with females who have been exposed to maternal infection.
"In our primary analysis, there was no significant difference in the odds of being diagnosed with JIA based on maternal infection exposure (OR = 1.02, 95%CI: 0.78 - 1.34)," investigators stated. "When stratified by infant sex, the odds of being diagnosed with JIA were higher for females (OR = 1.12, 95%CI: 0.79 - 1.57) than males (OR = 0.85, 95%CI: 0.53 - 1.37), but this result was not statistically significant (interaction p = 0.39)."
When looking at specific categories of the juvenile condition, RF-negative polyarticular JIA, persistent oligoarticular JIA, and enthesitis-related arthritis were the only subsets with enough data to be analyzed. There were no statistically significant increseases or decreases in the odds ratios of these categories.
In the study, as in the general disease population, more than half (68%) of JIA cases were represented in females. Cases of children who were under the age of 20 years old with JIA between 1997-2010 were utilized. Investigators used logistic regression to calculate adjust odds ratios and 95% confidence intervals.
With data obtained from a tertiary care hospital database in Washington state, 1290 JIA cases were included and 6072 control cases were matched on the birth year. Washington state birth records from 1980-2006 were used to collect information regarding maternal infection.
"This study is an initial exploration of fetal response to infection as a mechanism for JIA," investigators wrote. "While we did not find an overall association between JIA and maternal infection, our results suggest that future studies focused on the individual categories of JIA and gender related differences should be considered."
The study, "Association of juvenile idiopathic arthritis with maternal infection: a case control study" was published in Pediatric Rheumatology.
This article was published by our sister publication HCP Live.
FDA approves tocilizumab-bavi as biosimilar for PJIA, SJIA in children 2 years and up
October 2nd 2023Tocilizumab-bavi (Tofidence; Biogen) demonstrated a biosimilarity to tocilizumab (Actemra; Genentech) based on multifaceted clinical and non-clinical data for polyarticular juvenile idiopathic arthritis (PJIA) and systemic juvenile idiopathic arthritis (sJIA) in children aged 2 years and up. This makes it the first tocilizumab biosimilar to be FDA-approved in the United States, according to Biogen.
Secukinumab receives expanded approvals in EU for pediatric arthritic conditions
July 5th 2022The approvals were based on results from the JUNIPERA trial, which showed secukinumab reduced the risk of flare and disease activity when compared with placebo over 2 years in pediatric patients with ERA and JPsA.
RHEUMATOLOGY: Evaluating potential rheumatic diseases
November 1st 2013Laboratory tests are not very helpful when trying to determine whether a child with musculoskeletal complaints has any of the rheumatic diseases of childhood, and using adult models to evaluate these children is equally ineffective.
Update on Pediatric Rheumatology
July 1st 2007ABSTRACT: Dramatic progress has been made in our understanding of pediatric rheumatic disease. Various classification systems help identify juvenile idiopathic arthritis (JIA), which involves unique considerations that distinguish it from rheumatoid arthritis in adults. Vaccination issues are important for children with JIA. Renal involvement with systemic lupus erythematosus (SLE) is more common and more severe in children than in adults, but treatment of children who have SLE is similar to that of adults. Neonatal lupus erythematosus may occur in infants whose mothers have SLE. Juvenile dermatomyositis is associated with significant morbidity and mortality. Kawasaki disease is a common vasculitis of childhood, especially in infants and toddlers. Each of at least 8 major familial periodic fever clinical syndromes has specific distinguishing characteristics.